Cargando…
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system
Current treatment modalities for the neurodegenerative disease multiple sclerosis (MS) use disease-modifying immunosuppressive compounds but do not promote repair. Although several potential targets that may induce myelin production have been identified, there has yet to be an approved therapy that...
Autores principales: | Williams, Jessica L., Patel, Jigisha R., Daniels, Brian P., Klein, Robyn S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010893/ https://www.ncbi.nlm.nih.gov/pubmed/24733828 http://dx.doi.org/10.1084/jem.20131224 |
Ejemplares similares
-
ACKR4 restrains antitumor immunity by regulating CCL21
por: Whyte, Carly E., et al.
Publicado: (2020) -
Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy
por: Reddy, Adarsh S., et al.
Publicado: (2013) -
TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination
por: Gouna, Garyfallia, et al.
Publicado: (2021) -
Cooperating Mechanisms of CXCR5 and CCR7 in Development and Organization of Secondary Lymphoid Organs
por: Ohl, Lars, et al.
Publicado: (2003) -
Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology
por: Chatterjee, Madhumita
Publicado: (2022)